Fig. 5From: Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012–2018Overall survival for patients with NSQ/other histology receiving a second line of therapy in the pre-ICI and post-ICI periods. Index date represents the start of second-line therapy. CI Confidence interval, ICI Immune checkpoint inhibitor, NSQ Non-squamous cell, OS Overall survivalBack to article page